← Leaderboards
Zhi-Ren Liu
Proda Biotech, Llc
$15,017,308
Attributed
$16,010,863
Total exposure
11
Grants
10
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $2.5M · FY2005–25$5M$3.8M$2.5M$1.3M$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$16,010,863 · 11
By mechanism
R01$7,178,951 · 5
U44$5,993,341 · 2
R42$1,999,560 · 1
R21$671,990 · 2
R41$167,021 · 1
Top collaborators
- Bassel El-Rayes2 shared
- Alton B Farris1 shared
- Jenny J Yang1 shared
Others in their field
Top investigators on “Proteins”
- David Heimbrook · Leidos Biomedical Research, Inc.$354,061,551
- Randall J Bateman · Washington University$187,292,085
- Paul S. Aisen · Cognition Therapeutics, Inc.$175,382,342
- Reisa A. Sperling · Banner Health$145,046,481
- Barton F Haynes · Duke University$136,029,850
- Joseph L Goldstein · University Of Texas Sw Med Ctr/Dallas$102,433,280
Research focus
ProteinsCellsMalignant NeoplasmsXenograft ProcedureNeoplasm MetastasisSiteBinding SitesResearch Project GrantsTumorCancer CellDesignTissuesPlayPropertyToxic EffectMolecularDiagnosisCancer PatientMouse ModelNude MiceIntegrinsPharmaceutical PreparationsDoseEndothelial Cells
Grant awards (36)
ProAgio in Pancreatic Cancer$577,819
R01 · FY2025 · CA
Development of a protein drug for pancreatic cancer treatment$1,515,867
U44 · FY2024 · CA · contact PI
ProAgio in Pancreatic Cancer$590,094
R01 · FY2024 · CA
Development of a protein drug for pancreatic cancer treatment$1,515,866
U44 · FY2023 · CA · contact PI
A treatment drug for triple negative breast cancer$999,562
U44 · FY2023 · CA · contact PI
A treatment drug for triple negative breast cancer$999,562
U44 · FY2022 · CA · contact PI
Development of a protein drug for pancreatic cancer treatment$962,484
U44 · FY2022 · CA · contact PI
Pre-clinical Validation of A Novel Protein Drug Candidate for ASH and NASH Treatment$614,398
R01 · FY2021 · DK · contact PI
Development of a protein drug for pancreatic cancer treatment$999,780
R42 · FY2019 · CA · contact PI
Development of a protein drug for pancreatic cancer treatment$999,780
R42 · FY2018 · CA · contact PI
Development of anti-angiogenesis therapy targeting integrin$392,384
R01 · FY2018 · CA · contact PI
P68 and Ca-calmodulin interaction in cell migration$233,100
R01 · FY2018 · CA · contact PI
Development of anti-angiogenesis therapy targeting integrin$393,091
R01 · FY2017 · CA · contact PI
P68 and Ca-calmodulin interaction in cell migration$233,100
R01 · FY2017 · CA · contact PI
Development of a protein drug for pancreatic cancer treatment$167,021
R41 · FY2017 · CA · contact PI
Development of anti-angiogenesis therapy targeting integrin$393,783
R01 · FY2016 · CA · contact PI
P68 and Ca-calmodulin interaction in cell migration$233,100
R01 · FY2016 · CA · contact PI
Development of anti-angiogenesis therapy targeting integrin$400,331
R01 · FY2015 · CA · contact PI
P68 and Ca-calmodulin interaction in cell migration$233,100
R01 · FY2015 · CA · contact PI
PKM2 coordinates glycolysis and glutaminolysis in cancer cells$160,950
R21 · FY2015 · CA · contact PI
Development of anti-angiogenesis therapy targeting integrin$412,996
R01 · FY2014 · CA · contact PI
P68 and Ca-calmodulin interaction in cell migration$233,100
R01 · FY2014 · CA · contact PI
PKM2 coordinates glycolysis and glutaminolysis in cancer cells$193,140
R21 · FY2014 · CA · contact PI
Functional role of p68 tyrosine phosphorylation in cancer metastasis$213,051
R01 · FY2011 · CA · contact PI
Functional role of p68 tyrosine phosphorylation in cancer metastasis$219,640
R01 · FY2010 · CA · contact PI
Functional role of p68 tyrosine phosphorylation in cancer metastasis$219,640
R01 · FY2009 · CA · contact PI
Functional role of p68 tyrosine phosphorylation in cancer metastasis$219,640
R01 · FY2008 · CA · contact PI
Molecular MR Imaging by Targeting Cancer Markers$144,500
R21 · FY2008 · CA · contact PI
Biochemical Characterization of p68 RNA Helicase$241,696
R01 · FY2007 · GM · contact PI
Functional role of p68 tyrosine phosphorylation in cancer metastasis$219,640
R01 · FY2007 · CA · contact PI
Molecular MR Imaging by Targeting Cancer Markers$173,400
R21 · FY2007 · CA · contact PI
Biochemical Characterization of p68 RNA Helicase$23,361
R01 · FY2007 · GM · contact PI
Biochemical Characterization of p68 RNA Helicase$211,344
R01 · FY2006 · GM · contact PI
Biochemical Characterization of p68 RNA Helicase$216,431
R01 · FY2005 · GM
Biochemical Characterization of p68 RNA Helicase$216,431
R01 · FY2004 · GM
Biochemical Characterization of p68 RNA Helicase$237,681
R01 · FY2003 · GM